Frequency of Hematological Response in Patients with Chronic Myeloid Leukemia (Chronic Phase) with Imatinib After Three Months Presenting to CMH Rawalpindi

Frequency of Hematological Response in Patients with Chronic Myeloid Leukemia (Chronic Phase) with Imatinib After Three Months Presenting to CMH Rawalpindi

Objective: To find the frequency of haematological response in patients of chronic myeloid leukaemia (Chronic Phase) after three months of Imatinib Mesylate therapy, presenting to CMH Rawalpindi Study Design: Cross-sectional study. Place and Duration of Study: Department of Oncology Combined Mi...

Full description

Bibliographic Details
Main Authors: Anil Babar, Riaz Ahmed, Ahmed Raza, Zulfiqar Ali Amin, Muhammad Nadeem Piracha, Anum Zargham, Ibtisam Idrees
Format: Article
Language:English
Published: Army Medical College Rawalpindi 2024-04-01
Series:Pakistan Armed Forces Medical Journal
Subjects:
Chronic Myeloid Leukemia
Chronic Phase
Imatinib Mesylate
Online Access:https://www.pafmj.org/PAFMJ/article/view/7036

Internet

https://www.pafmj.org/PAFMJ/article/view/7036

Similar Items